Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-203374

Chief Operating Officer acquired 11,770 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hensley Mark Earl · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-30 Exercise or conversion : show line 1 in the form +11,770 11,770 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-30 Exercise or conversion : show line 2 in the form Restricted Stock Units −11,770 176,545 D
Loading xslF345X06/ownership.xml…